triflusal has been researched along with Myocardial Ischemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuertes Ferre, G; Galache Osuna, JG; Laita Monreal, S; Ortas Nadal, MDR; Sánchez Insa, E; Sánchez Rubio-Lezcano, J | 1 |
Alvarez-Sabín, J; Maisterra, O; Quintana, M; Santamarina, E | 1 |
Calpe Climent, AV; Horrach Pérez, M; Llobera C-anaves, J; Peña Díaz, JJ; Rodríguez Moreno, C; Thomàs Mulet, V; Tomàs Arbona, FJ | 1 |
De La Cruz, JP; Del Prado, MF; Prieto, MA; Sánchez de la Cuesta, F | 1 |
2 trial(s) available for triflusal and Myocardial Ischemia
Article | Year |
---|---|
Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
Topics: Aged; Aspirin; Brain Ischemia; Dyspepsia; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Recurrence; Salicylates; Secondary Prevention; Vascular Diseases | 2014 |
Influence of triflusal on platelet activation after coronary artery bypass graft.
Topics: Adenosine Diphosphate; Adult; Aged; beta-Thromboglobulin; Collagen; Coronary Artery Bypass; Erythrocyte Count; Female; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Ischemia; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Salicylates; Thromboxane B2; Time Factors | 2000 |
2 other study(ies) available for triflusal and Myocardial Ischemia
Article | Year |
---|---|
Triflusal in Patients With Aspirin Hypersensitivity Treated With Coronary Stent Implantation.
Topics: Aged; Aspirin; Drug Hypersensitivity; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Salicylates; Stents | 2018 |
[Prescription of platelet antiaggregants in secondary prevention of ischemic heart disease].
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Dipyridamole; Drug Prescriptions; Family Practice; Female; Humans; Male; Medical Audit; Medicine; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Primary Health Care; Salicylates; Spain; Specialization; Ticlopidine; Urban Population | 1996 |